Tamoxifen-induced growth of leiomyomas. A case report.
Tamoxifen, a nonsteroidal estrogen agonist-antagonist, is used in the treatment of breast cancer. A postmenopausal woman, aged 73, while being treated with Tamoxifen, developed continuous growth of her myomatous uterus, became symptomatic and required surgery. Tamoxifen at a dose of 40 mg/d has been associated with endometrial carcinoma. The growth of myomas seen with Tamoxifen in this patient seems to be a result of its direct agonist properties.